-
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
Science
-
Research updates, February 27
-
PolyBio announces $15 million in Long Covid research funding, new projects studying viral persistence
-
Long Covid surveys from a FDA/NIH initiative ask which drugs help alleviate symptoms
-
Research updates, February 20
-
Covid-19 reinfections are further disabling people with Long Covid
-
Q&A: Melissa Stockwell on Long Covid in children, how RECOVER aims to answer questions
Covid-19
Health
-
“This exhaustion is cellular”: Excerpts from the new book ‘What Is Myalgic Encephalomyelitis Like?’
-
There’s a long history of person-first language in advocacy. Here’s why we should use it for Long COVID.
-
The (sick) kids aren’t alright: Observations from a teacher with Long COVID
-
Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peers